High prevalence of myocardial ischemia and vasoconstrictive hormonal release in hypertension during chronic renal failure

Nephron

Volumn 76, Issue 4, 1997, Pages 434-444

  Napoli, Claudio ^a   Di Gregorio, Fernando ^b,d   Sorice, Pompeo ^a   Di Benedetto, Attilio ^a   Ciafre, Silvia ^e   Posca, Teresa ^c   Ferrara, Alessandro ^a   Bruzzese, Giuseppe ^a   D’Armiento, Francesco Paolo ^c   Mansi, Luigi ^b   Liguori, Antonio ^a  

^a Department of Cardiology CCU   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Nuclear Medicine Departement   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Chronic renal failure; Endothelin 1; Hypertension; Left ventricular hypertrophy; Myocardial ischemia; Norepinephrine

Indexed keywords

CATECHOLAMINE DERIVATIVE; ENDOTHELIN 1; HORMONE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NORADRENALIN; RADIOISOTOPE; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; HEART MUSCLE ISCHEMIA; HORMONE RELEASE; HUMAN; HYPERTENSION; MALE; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; UREMIA;

EID: 0030836487     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190226     Document Type: Article

References (54)

1. Slamler J, Wentworth DN, Neaton JD: Blood pressure (systolic and diastolic) and risk of fatal coronary heart disease, Hypertension 1989:13 (suppl 1):2-12.
2. Casale PN, Devereux RB, Milner M, et al: Value of echocardiographic left ventricular mass in predicting cardiovascular morbid events in hypertensive men, Ann Intern Med 1986:105: 173-178.
3. Huling J, Kramer W, Ciiarra B, Laurent G, Wizemann V, Schutterle G: Asymmetric septal hypertrophy and left atrial dilatation in patients with end-stage renal disease long-term hemodialysis, Clin Nephrol 1989;32:276-283.
4. Silberberg JS, Barre PE, Prichard SS, Snidcr-man AD: Impact of left ventricular hypertrophy on survival in end-stage renal disease, Kidney Int 1989:36:286-290.
5. Paracuollo D, Esposito E, Di Benedetto A, Soricc P, Giuliani F, Di leso N, Liguori A: Cardiac morphology evaluation in patients with chronic renal failure: in Andreucci VE, Dal Canton A (eds): New Therapeutic Strategies in Nephrology, Norwcll, Kluwer Academic Publishers, 1991. pp 162-168.
6. Cooke RC, Gann DS, Whelton PK, Hsu TH, Bledsoe T, Moore MA, Walker G: Hormonal responses to acute volume changes in ancphric subjects, Kidney Int 1983:23:71-78.
7. Burges ED: Cardiac vagal dcncrvation in hemodialysis patients, Nephron 1982:30:228-230.
8. Corder GN, Sharma J, McDonald RH: Variable levels of plasma catecholamines and dopamine beta-hydroxylasc in hemodialysis patients, Nephron 1980:25:267-272.
9. Rcmmc WJ, Kruyssen DA, Look MP, Bootsma M, dc Lccuw PW: Systemic and cardiac neuroendocrine activation and severity of myocardial ischemia in humans, J Am Coll Cardiol 1994:23:82-91.
10. Bernardi D, Bernini L, Cini G, Ghione S, Bo-nechi I: Asymmetric septal hypertrophy and sympathetic overactivity in normotensive he-modialvzed patients, Am Heart J 1985:109: 539-545.
11. Vanhoutte PM: Is endothelin involved in the pathogenesis of hypertension? Hypertension 1993:21:747-751.
12. Kohno M, Yasunari K, Murakawa KI, et al: Plasma immunoreactivc endothelin in essential hypertension, Am J Med 1990:88:614- 618.
13. Shichiri M, Hirata Y, Ando K, et al: Plasma endothelin levels in hypertension and chronic renal failure, Hypertension 1990:15:493-496.
14. Kovama H, Tabata T, Nishizawa Y, Inouc T, Morii H, Yamaj I: Plasma endothelin levels in patients with uremia, Lancet 1989;:991 -992.
15. Yasuda M, Konho M, Thara A, et al: Circulating immunoreactivc endothelin in ischemic heart disease, Am Heart J 1990:119:801 -806.
16. Watanabe T, Suzuki N, Shimamoto N, et al: Endothelin in myocadial infarction, Nature 1990:334:114.
17. Yang Z, Richard V, Von Segesser L, et al: Threshold concentrations of endothclin-1 potentiate contractions to norepinephrine and serotonin in human arteries: A new mechanism of vasospasm? Circulation 1990:82:188-195.
18. Tovo-oka T, Aizawa T, Suzuki N, et al: Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris, Circulation 1991:83: 476-483.
19. Clozel JP, Sprecher U: Influence of low perfusion pressure on effect of endothelin on coronary vascular bed, Am J Physiol 1991:260: H893-H901.
20. Ray SG, McMurray JJ, Morton JJ, Dargic HJ: Circulating endothelin in acute ichcmic syndromes, Br Heart J 1992:67:383-386.
21. Petersen CL, Hansen A, Frandsen E, et al: Endothelin release and enhanced regional myocardial ischemia induced by cold-air inhalation in patients with stable angina, Am Heart J 1994;128:511-516.
22. Pepine CJ: Circadian variations in myocardial ischemia: Implications for management, JAMA 1991;265:386-390.
23. Rocco MB, Nabel EG, Selwvn AP: Circadian rhythms and coronary artery disease, Am J Cardiol 1987:59:13C-17C
24. Amadi A, Ponikowski P, Coats AJS: Role of catecholamines and sympathetic activation as a risk factor for coronary' artery disease, J Car-diovasc Risk 1995:2:222-228.
25. Helin P, Lorenzen I, Garbarsch C, Mathicscn ME: Arteriosclerosis in rabbit aorta induced by noradrenaline, Atherosclerosis 1970; 12:125- 132.
26. Sahn DJ, DcMaria A, Kisslo J, Weyman A: The Committee on M-Modc Standardization of the American Society of Echocardiography, Recommendations regarding quantitation in M-modc echocardiography: Result of a survey of echocardiographic measurements, Circulation 1978:58:1072-1083.
27. Henschkc CI, Risser TA, Sandor T, Hanlon WB, Neumann A, Wynne J: Quantitative computer-assisted analysis of left ventricular wall thickening and motion by 2-dimensional echocardiography in acute myocardial infarction, Am J Cardiol 1983:52:960-964.
28. Leppo JA, DePucy EG, Johnson LL: A review of cardiac imaging with Sestamibi and Tebo-roxime, J Nucl Med 1991;32:2012-2022.
29. Liguori A, Di Gregorio F, Napoli C, et al: Atrial natriuretic factor and sympathetic activation in human heart failure, Eur J Pharmacol Sei 1994; 16:61-67.
30. Ciafrfc SA, D'Armicmo FP, Liguori A, et al; Angiotensin II evokes the release of ET-I from human endothelial cells in vitro, Am J Clin Pathol 1992;98:379-380.
31. Liguori A, Di Gregorio F, Napoli C, et al: Effects of blood loading on left ventricular function in chronic uremics with arterio-vc-nous fistula, Chest 1993:103(suppl A):192S
32. Smart SC: The clinical utility of echocardiography in the assessment of myocardial viability, J Nucl Med 1994;35(suppl):49S-58S
33. WmMIBI in relation to wall motion after thrombolysis for acute myocardial infarction, Nucl MedCommun 1993;14:310-317.
34. Tamaki N, Kawamoto M, Yonekura Y, et al: Regional metabolic abnormality in relation to perfusion and wall motion in patients with myocardial infarction: Assessment with emission tomography using an iodinated branched fatty acid analog, J Nucl Med 1992:33:659- 667.
35. Foley RN, Parfrey PS, Harnett JD, Kent JM, Murray DC, Barre PE: The prognostic importance of left ventricular geometry in uremic cardiomyopathy, J Am Soc Nephrol 1995;5: 2024-2037.
36. Parfrey PS, Harnett JD, Griffiths SM, et al: The clinical course of left ventricular hypertrophy in dialysis patients, Nephron 1990:55: 114-120.
37. Liguori A, Napoli C, Sorice P, et al: Early alteration of left ventricular diastolic function in hypertensive patients on maintenance hemodialysis, Kidney Ini 1993:43:759-760.
38. Napoli C, Liguori A, Sorice P, Di Benedetto A, Ciafrc S, Posca T, Di Ieso N, D’Armiento FP: Relations between vasoactive hormones and diastolic function in hypertensive uremics, J Intern Med 1996;240:389-394.
39. Foley RN, Parfrey PS, Harnett JD, Kent JM: Impact of hypertension on cardiomyopathy, morbidity, and mortality in end-stage renal disease, Kidney lot 1996:49:1379-1383.
40. Houghton JF, Frank MJ, Carr AA, von Dohlen TW, Pisant LLM: Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease, J Am Coll Cardiol 1990:15:43- 51.
41. Opherk D, Mall G, Zcbc H, et al: Reduction of coronary reserve: A mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries, Circulation 1984:69: 1-7.
42. Roberts CS, Roberts WC: Cross-sectional area of the proximal portions of the three major cpi-cardial coronary arteries in 98 necropsy patients with different coronary events: Relationships to heart weight, age and sex, Circulation 1980:62:953-959.
43. James TN: Morphologic characteristics and functional significance of focal fibromuscular dysplasia of small coronary arteries, Am J Cardiol 1990:65:12G-22G
44. Wasserman AG, Katz RG, Varghese PJ, et al: Exercise radionuclide ventriculographic responses in hypertensive patients with chest pain, N Engl J Med 1984:311:1276-1280.
45. Guideline for clinical use of cardiac radionuclide imaging, Report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures, J Am Coll Cardiol 1995:25:521-547.
46. Pringle SD, Dunn FG, Tweddel AC, et al: Symptomatic and silent myocardial ischemia in hypertensive patients with left ventricular hypertrophy, Br Heart J 1992:67:377-382.
47. Rostand SG, Rutsky EA: Ischemic heart disease in chronic renal failure: Management considerations, Semin Dial 1989:2:98-101.
48. Amann K, Wiest G, Zimmer G, Gretz N, Ritz E, Mall G: Reduced capillary density in the myocardium of uremic rats, Kidney Int 1992: 42:1079-1085.
49. Wheeler DC, Swcny P, Varhesc Z: Hvperlipid-cmiaand atherosclerosis in chronic dialysis patients: in Maher JF (ed): Replacement of Renal Function by Dialysis, Boston, Kluwer Academic Publishers, 1989. pp 798-807.
50. Mulcahy D, Cunnhingham D, Crean P: Circadian variation of total ischemic burden and its alterations with anti-anginal agents, Lancet 1988;2:755-758.
51. Simpson P, McGrath A, Sevion S: Myocyte hypertrophy in neonatal heart cultures and its regulation by catecholamines, Circ Res 1982: 51:787-801.
52. Fröhlich ED: Hemodynamics and other determinants in the development of left ventricular hypertrophy, Fed Proc 1983:42:2709-2715.
53. Falatico R, Underwood DC, Cheung WM, et al: Coronary vasoconstrictor and arrhythmo-genic properties of endothelin in the dog, Pharmacologist 1989:31:150-155.
54. Chesebro JH, Fustcr V, Webster MWI: Endothelial injury and coronary vasomotion, J Am Coll Cardiol 1989; 14:1181 -1190.